Deutsche Bank
OCRX

Deutsche Bank’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Deutsche Bank’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,800
Closed -$4K – 5266
2017
Q2 		$4K Buy
3,800
+3,600
+1,800% +$4.18K ﹤0.01% 4790
2017
Q1 		$0 Buy
+200
New +$255 ﹤0.01% 5255
2016
Q3 		– Sell
-82
Closed – – 5409
2016
Q2 		$0 Hold
82
– – ﹤0.01% 5467
2016
Q1 		$0 Sell
82
-367
-82% -$1.05K ﹤0.01% 5463
2015
Q4 		$1K Sell
449
-10,261
-96% -$35.1K ﹤0.01% 5224
2015
Q3 		$33K Buy
10,710
+10,343
+2,818% +$39.8K ﹤0.01% 4612
2015
Q2 		$1K Sell
367
-5,375
-94% -$20.6K ﹤0.01% 5297
2015
Q1 		$25K Sell
5,742
-9,392
-62% -$54.1K ﹤0.01% 4605
2014
Q4 		$96K Buy
+15,134
New +$88.5K ﹤0.01% 4747
2014
Q2 		– Sell
-1,000
Closed -$10K – 6203
2014
Q1 		$10K Sell
1,000
-28,887
-97% -$413K ﹤0.01% 5047
2013
Q4 		$387K Buy
29,887
+8,969
+43% +$83.8K ﹤0.01% 3288
2013
Q3 		$176K Buy
20,918
+13,987
+202% +$113K ﹤0.01% 4184
2013
Q2 		$39K Buy
+6,931
New +$43.1K ﹤0.01% 4596

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Deutsche Bank's OCRX Position: Q3 2017 in Review

Deutsche Bank sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2017, closing a stake of 3,800 shares — an estimated $4K sold.

Deutsche Bank first reported a position in OCRX in Q2 2013 and held it in 13 quarters. The position peaked at $387K in Q4 2013. 21 funds tracked by Wall St. Rank hold OCRX as of Q3 2017.

  • Deutsche Bank reported no remaining Ocera Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Deutsche Bank sold 3,800 Ocera Therapeutics, Inc. shares in Q3 2017, an estimated $4K.
  • Deutsche Bank first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 13 quarters.
  • Deutsche Bank's Ocera Therapeutics, Inc. position peaked at $387K in Q4 2013.
  • 21 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2017.

Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.